xonvea magasýruþolin tafla 10 mg/10 mg
campuspharma ab - pyridoxinum hýdróklóríð; doxylaminii hýdrógen súkkínat - magasýruþolin tafla - 10 mg/10 mg
orfadin
swedish orphan biovitrum international ab - nitisinón - tyrosinemias - Önnur meltingarvegi og efnaskipti vörur, - hereditary tyrosinemia type 1 (ht 1)orfadin is indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht 1) in combination with dietary restriction of tyrosine and phenylalanine. alkaptonuria (aku)orfadin is indicated for the treatment of adult patients with alkaptonuria (aku).
amitriptylin abcur filmuhúðuð tafla 50 mg
abcur ab* - amitriptylinum hýdróklóríð - filmuhúðuð tafla - 50 mg
amitriptylin abcur filmuhúðuð tafla 10 mg
abcur ab* - amitriptylinum hýdróklóríð - filmuhúðuð tafla - 10 mg
amitriptylin abcur filmuhúðuð tafla 25 mg
abcur ab* - amitriptylinum hýdróklóríð - filmuhúðuð tafla - 25 mg
clarityn tafla 10 mg
bayer ab - loratadinum inn - tafla - 10 mg
ngenla
pfizer europe ma eeig - somatrogon - growth and development - sterum og undirstÚku hormÓn og hliÐstÆÐum - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.
darunavir medical valley filmuhúðuð tafla 600 mg
medical valley invest ab - darunavir propylene glycolate - filmuhúðuð tafla - 600 mg
darunavir medical valley filmuhúðuð tafla 800 mg
medical valley invest ab - darunavir propylene glycolate - filmuhúðuð tafla - 800 mg
metronidazol baxter viaflo innrennslislyf, lausn 5 mg/ml
baxter medical ab - metronidazolum inn - innrennslislyf, lausn - 5 mg/ml